Effectiveness and Safety of Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive and Oligometastatic Hepatocellular Carcinoma
Systemic therapy combined with SBRT was effective and safe for OP and OM HCC. SBRT may delay next-line systemic therapy by blocking OP.
Authors
- Zhuo Song (ORCID: https://orcid.org/0000-0003-1494-7070)
- Zhiyan Liu (ORCID: https://orcid.org/0000-0001-9668-7756)
- Rongxu Du
- Xuan Zheng (ORCID: https://orcid.org/0000-0001-9147-2828)
- Yongheng Li (ORCID: https://orcid.org/0000-0002-2101-2014)
- Yangzi Zhang (ORCID: https://orcid.org/0000-0001-7371-1709)
- Yong Cai (ORCID: https://orcid.org/0000-0002-8862-2909)
- Maxiaowei Song
- Shuai Li
- Dezuo Dong (ORCID: https://orcid.org/0000-0001-6008-7193)
- Hongzhi Wang (ORCID: https://orcid.org/0000-0002-7521-2871)
- Jianhao Geng
- Xianggao Zhu (ORCID: https://orcid.org/0000-0002-6739-8047)
- Weihu Wang (ORCID: https://orcid.org/0000-0003-4969-398X)
Institutions
- Peking University (CN)
- Peking University Cancer Hospital (CN)
- Ministry of Education (ET)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/jhc.s519770
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- National Natural Science Foundation of China
- Beijing Municipal Administration of Hospitals